Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy

Circulating tumor cells (CTCs) are considered as surrogate markers for prognosticating and evaluating patient treatment responses. Here, 226 blood samples from 92 patients with breast cancer, including patients with newly diagnosed or metastatic refractory cancer, and 16 blood samples from healthy s...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoo, Bee Luan, Lee, Soo Chin, Kumar, Prashant, Tan, Tuan Zea, Warkiani, Majid Ebrahimi, Ow, Samuel GW., Nandi, Sayantani, Lim, Chwee Teck, Thiery, Jean Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558172/
https://www.ncbi.nlm.nih.gov/pubmed/26008969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558172/
https://www.ncbi.nlm.nih.gov/pubmed/26008969

Ejemplares similares